Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $24.7 million.

  • RxSight's Non-Current Assets rose 402.94% to $24.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.2 million, marking a year-over-year increase of 2924.04%. This contributed to the annual value of $24.7 million for FY2024, which is 7492.75% up from last year.
  • According to the latest figures from Q3 2025, RxSight's Non-Current Assets is $24.7 million, which was up 402.94% from $25.1 million recorded in Q2 2025.
  • RxSight's Non-Current Assets' 5-year high stood at $25.1 million during Q2 2025, with a 5-year trough of $13.9 million in Q3 2023.
  • Over the past 5 years, RxSight's median Non-Current Assets value was $16.7 million (recorded in 2022), while the average stood at $18.7 million.
  • Per our database at Business Quant, RxSight's Non-Current Assets tumbled by 1596.35% in 2023 and then soared by 7492.75% in 2024.
  • Quarter analysis of 5 years shows RxSight's Non-Current Assets stood at $16.4 million in 2021, then dropped by 4.97% to $15.6 million in 2022, then decreased by 9.39% to $14.1 million in 2023, then skyrocketed by 74.93% to $24.7 million in 2024, then dropped by 0.34% to $24.7 million in 2025.
  • Its Non-Current Assets stands at $24.7 million for Q3 2025, versus $25.1 million for Q2 2025 and $24.6 million for Q1 2025.